SOURCE: Xtalks

Xtalks Webinars

October 27, 2014 07:05 ET

Pre-Filled Syringes in Clinical Trials, Live Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - October 27, 2014) - In this webinar, the presenter, Pamela Osborne, Senior Clinical Supply Chain Manager at Fisher Clinical Services, will examine the growth of pre-filled syringes, the factors contributing to this growth, and the key role technological advances in syringe assembly and labeling are playing in this expanding area. Join this interactive webinar to learn more on Thursday, November 6, 2014 at 11am EST (4pm GMT).

After decades of domination by small-molecule drugs, one could say that the pharmaceutical industry is increasingly thinking large. More than 60% of drugs currently in clinical development are biologics for parenteral administration.

The small-to-large molecule shift is giving the pre-filled syringe market a shot in the arm, making it one of the fastest growing segments of the injectable drug delivery device market. According to the National Institutes of Health, 44 clinical studies are enrolling a total of 12,000 patients in order to test drugs using these delivery devices. That's an increase from merely a handful of clinical trials utilizing pre-filled syringes in 2010.

Three of the top 10 selling drugs in the past year are administered via pre-filled syringe. The global market for these delivery devices is projected to reach $5 billion in 2019, up from $2 billion in 2012. This robust growth reflects the compelling benefits of pre-filled syringes for drug manufacturers, healthcare providers and patients compared to conventional vial and ampule packaging.

In 2010, Fisher Clinical Services began working with a large pharmaceutical company to develop an automated solution for assembling and labeling these devices. Three years since initiating the service, the company has assembled and labeled more than five million syringes for a variety of customers. Campaigns generally range between 500 and 50,000 syringes, with the largest numbering 250,000 units.

In the years since the service started, expansion of the pre-filled syringe market has continued for several reasons: Patent expiries for biologics are creating a new and competitive market for biosimilars, a new class of drugs expected to increase the availability of affordable medicines. Developing a biosimilar in a prefilled syringe may give it an advantage compared to generic rivals and the innovator therapy. For the same competitive reason, some companies are looking to make the switch from a vial presentation to syringe. Market growth is also due to changing medical practices, including a rise in self-administration of drugs to contain healthcare costs and immunizations taking place outside traditional medical settings. A swelling population of elderly are living longer with chronic diseases, such as diabetes and rheumatoid arthritis, which require frequent parenteral dosing.

Finally, there is the substantial impact of technological innovations that have transformed the assembly and labeling of pre-filled syringes. With trials of biologicals climbing in volume, size and complexity, manual assembly and labeling of pre-filled syringes for studies -- once standard practices -- are no longer viable options for any but the smallest studies. Nor do they need to be.

Using the latest automated equipment, Fisher Clinical Services assembles and labels tens of thousands of pre-filled syringes of every size and shape with precision and speed. Afterward, new shipping options ensure that pre-filled syringes reach investigator sites across the globe in pristine condition.

As with all clinical trials, studies using pre-filled syringes require well-thought-out clinical supply plans and, increasingly, an innovative supply chain partner capable of offering flexibility alongside precision automation and global processes.

To learn more about this event visit:  Pre-Filled Syringes in Clinical Trials

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit
For information about hosting a webinar visit

Image Available:

Contact Information